Ruhe Ann Marie, Qureshi Imran, Procaccini David
(Corresponding author) Clinical Pharmacy Specialist, Psychiatry, Sheppard Pratt Health System, Baltimore, Maryland,
Clinical Pharmacy Specialist, Psychiatry, The Johns Hopkins Hospital, Baltimore, Maryland.
Ment Health Clin. 2018 Nov 1;8(6):313-316. doi: 10.9740/mhc.2018.11.313. eCollection 2018 Nov.
DiGeorge Syndrome (22q11.2 deletion syndrome) is a chromosomal disorder associated with both congenital heart malformations and schizophrenia, which is often treatment-resistant and may warrant treatment with clozapine. Clozapine-induced myocarditis (CIM) is a rare complication of clozapine therapy, with a reported incidence ranging from 0.015% to 3%. Fulminant CIM has a nonspecific presentation in both adult and pediatric populations and a mortality rate approaching 50%. Few cases of pediatric CIM have been documented in the literature. This report highlights a case of CIM in an adolescent male with DiGeorge Syndrome whose clinical course was characterized by a subtle, nonspecific presentation and resolution with supportive care.
迪乔治综合征(22q11.2缺失综合征)是一种与先天性心脏畸形和精神分裂症相关的染色体疾病,精神分裂症往往对治疗有抵抗性,可能需要使用氯氮平进行治疗。氯氮平诱发的心肌炎(CIM)是氯氮平治疗的一种罕见并发症,报告的发病率在0.015%至3%之间。暴发性CIM在成人和儿童人群中表现均不具有特异性,死亡率接近50%。文献中记载的儿童CIM病例很少。本报告重点介绍了一例患有迪乔治综合征的青少年男性CIM病例,其临床病程的特点是表现隐匿、不具有特异性,经支持治疗后病情缓解。